InvestorsHub Logo
Followers 28
Posts 4333
Boards Moderated 1
Alias Born 09/22/2006

Re: maumar post# 5495

Friday, 06/29/2018 5:45:40 PM

Friday, June 29, 2018 5:45:40 PM

Post# of 8545
I obviously don't have a crystal ball but PEGPH20 results by end of year is not that far away and we have not seen anything to question its efficacy, IMHO. Of course it could always fail, but then we have a profitable non-cancer themed arm of the company to fall back on. Remove the research cash burn and Halozyme is a very profitable company even now. In addition, the prospects for another deal are still there, but those odds are not so great. So it is very much a risk, but one that I can stomach.
-Fritz

The more you know, the less you don't know.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent HALO News